Photoantimicrobials—are we afraid of the light?

The Lancet Infectious Diseases

Volumn 17, Issue 2, 2017, Pages e49-e55

  Wainwright, Mark ^a   Maisch, Tim ^b   Nonell, Santi ^c   Plaetzer, Kristjan ^d   Almeida, Adelaide ^e   Tegos, George P ^f,g   Hamblin, Michael R ^f,g,h  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c INSTITUT QUÍMIC DE SARRIÀ   (Spain)

^d UNIVERSITY OF SALZBURG   (Austria)

^e UNIVERSITY OF AVEIRO   (Portugal)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; HALOGEN; MEMBRANE PROTEIN; PHOTOANTIMICROBIAL AGENT; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; BACTERIUM; COMMUNITY; DRUG EFFECT; DRUG MECHANISM; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; INFECTION CONTROL; LASER; LIGHT EMITTING DIODE; NONHUMAN; PARAMECIUM CAUDATUM; PHENOTYPE; PHOTODYNAMICS; PRIORITY JOURNAL; PROTOZOON; REVIEW; VETERINARY MEDICINE; VIRUS; ANIMAL; MULTIDRUG RESISTANCE;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PHOTOSENSITIZING AGENTS;

EID: 85006976127     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30268-7     Document Type: Review

References (75)

1. 1 ECDC. Surveillance report. Annual epidemiological report. Antimicrobial resistance and healthcare-associated infections. http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-annual-epidemiological-report.pdf, 2014 (accessed Oct 15, 2015).
2. 2 ECDC. Surveillance report. Annual epidemiological report. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. http://ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2012.pdf, 2012 (accessed Oct 15, 2015).
3. 3 WHO. Antimicrobial resistance. Global report on surveillance. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1, 2014 (accessed Oct 15, 2015).
4. 4 European Commission. Commission staff working document. Progress report on the action plan against the rising threats from antimicrobial resistance. http://ec.europa.eu/health/antimicrobial_resistance/docs/2015_amr_progress_report_en.pdf, 2015 (accessed Oct 16, 2015).
5. 5 Berendonk, T, Manaia, CM, Merlin, C, et al. Tackling antibiotic resistance: the environmental framework. Nat Rev Microbiol 13 (2015), 310–317.
6. 6 Hwang, T, Gibbs, KA, Podolsky, SH, Linder, JA, Antimicrobial stewardship and public knowledge of antibiotics. Lancet Infect Dis 15 (2015), 1000–1001.
7. 7 Spellberg, B, Bartlett, JG, Gilbert, DN, The future of antibiotics and resistance. N Engl J Med 368 (2013), 299–302.
8. 8 Ling, LL, Schneider, T, Peoples, AJ, et al. A new antibiotic kills pathogens without detectable resistance. Nature 517 (2015), 455–459.
9. 9 Hamblin, M, Hassan, T, Photodynamic therapy: a new antimicrobial approach to infectious disease?. Photochem Photobiol Sci 3 (2004), 436–450.
10. 10 Yin, R, Hamblin, MR, Antimicrobial photosensitizers: drug discovery under the spotlight. Curr Med Chem 22 (2015), 2159–2185.
11. 11 Raab, O, Über die Wirkung fluoreszcierender Stoffe aus Infusorien. Z Biol, 39, 1900, 524 (in German).
12. 12 Jesionek, A, von Tappeiner, H, Zur behandlung der hautcarcinome mit fluorescierenden stoffen. Arch Klin Med, 82, 1905, 223 (in German).
13. 13 Agostinis, P, Berg, K, Cengel, KA, et al. Photodynamic therapy of cancer: an update for clinicians. CA Cancer J Clin 61 (2011), 250–281.
14. 14 Vatansever, F, de Melo, WC, Avci, P, et al. Antimicrobial strategies centered around reactive oxygen species—bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol Rev 37 (2013), 955–989.
15. 15 Wainwright, M, Crossley, KB, Photosensitising agents—circumventing resistance and breaking down biofilms: a review. Int Biodeterior Biodegradation 53 (2004), 119–126.
16. 16 Lauro, F, Pretto, P, Covolo, L, Jori, G, Bertoloni, G, Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene–polylysine conjugates. Photochem Photobiol Sci 1 (2002), 468–470.
17. 17 Tegos, G, Hamblin, MR, Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob Agents Chemother 50 (2006), 196–203.
18. 18 Tegos, G, Masago, K, Aziz, F, Higginbotham, A, Stermitz, FR, Hamblin, MR, Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation. Antimicrob Agents Chemother 52 (2008), 3202–3209.
19. 19 Prates, R, Kato, IT, Ribeiro, MS, Tegos, GP, Hamblin, MR, Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans. J Antimicrob Chemother 66 (2011), 1525–1532.
20. 20 Vera, D, Haynes, MK, Ball, AR, et al. Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes. Photochem Photobiol 88 (2012), 499–511.
21. 21 Alves, E, Faustino, MA, Neves, MG, Cunha, A, Tome, J, Almeida, A, An insight on bacterial cellular targets of photodynamic inactivation. Future Med Chem 6 (2014), 141–164.
22. 22 Cieplik, F, Späth, A, Regensburger, J, et al. Photodynamic biofilm inactivation by SAPYR—an exclusive singlet oxygen photosensitizer. Free Radic Biol Med 65 (2013), 477–487.
23. 23 Dai, T, Fuchs, BB, Coleman, JJ, et al. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol, 3, 2012, 120.
24. 24 Banerjee, I, Douaisi, MP, Mondal, D, Kane, RS, Light-activated nanotube-porphyrin conjugates as effective antiviral agents. Nanotechnology, 23, 2012, 105101.
25. 25 Akilov, O, Kosaka, S, O'Riordan, K, et al. The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites. Chem Biol 13 (2006), 839–847.
26. 26 Maisch, T, Bosl, C, Szeimies, RM, Love, B, Abels, C, Determination of the antibacterial efficacy of a new porphyrin-based photosensitizer against MRSA ex vivo. Photochem Photobiol Sci 6 (2007), 545–551.
27. 27 Kömerik, N, Wilson, M, Poole, S, The effect of photodynamic action on two virulence factors of Gram-negative bacteria. Photochem Photobiol 72 (2000), 676–680.
28. 28 Tubby, S, Wilson, M, Nair, SP, Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent. BMC Microbiol, 9, 2009, 211.
29. 29 de Melo, W, Avci, P, de Oliveira, MN, et al. Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection. Expert Rev Anti Infect Ther 11 (2013), 669–693.
30. 30 Cieplik, F, Tabenski, L, Buchalla, W, Maisch, T, Antimicrobial photodynamic therapy for inactivation of biofilms formed by oral key pathogens. Front Microbiol, 12, 2014, 405.
31. 31 Nakonieczna, J, Michta, E, Rybicka, M, Grinholc, M, Gwizdek-Wiśniewska, A, Bielawski, KP, Superoxide dismutase is upregulated in Staphylococcus aureus following protoporphyrin-mediated photodynamic inactivation and does not directly influence the response to photodynamic treatment. BMC Microbiol, 10, 2010, 323.
32. 32 Dahl, T, Bilski, P, Reszka, KJ, Chignell, CF, Photocytotoxicity of curcumin. Photochem Photobiol 59 (1994), 290–294.
33. 33 Winter, S, Tortik, N, Kubin, A, Krammer, B, Plaetzer, K, Back to the roots: photodynamic inactivation of bacteria based on water-soluble curcumin bound to polyvinylpyrrolidone as a photosensitizer. Photochem Photobiol Sci 12 (2013), 1795–1802.
34. 34 Maisch, T, Eichner, A, Späth, A, et al. Fast and effective photodynamic inactivation of multiresistant bacteria by cationic riboflavin derivatives. PLoS One, 9, 2014, e111792.
35. 35 Cochrane, C, Mordon, SR, Lesage, JC, Koncar, V, New design of textile light diffusers for photodynamic therapy. Mater Sci Eng C Mater Biol Appl 33 (2013), 1170–1175.
36. 36 Yoshimura, M, Namura, S, Akamatsu, H, Horio, T, Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol 135 (1996), 528–532.
37. 37 Sahu, K, Sharma, M, Bansal, H, Dube, A, Gupta, PK, Topical photodynamic treatment with poly-L-lysine-chlorin p6 conjugate improves wound healing by reducing hyperinflammatory response in Pseudomonas aeruginosa-infected wounds of mice. Lasers Med Sci 28 (2013), 465–471.
38. 38 Avci, P, Gupta, A, Sadasivam, M, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg 32 (2013), 41–52.
39. 39 Sellera, F, Sabino, CP, Ribeiro, MS, et al. In vitro photoinactivation of bovine mastitis related pathogens. Photodiagnosis Photodyn Ther 13 (2016), 276–281.
40. 40 Selleraa, F, Gargano, RG, Libera, AM, et al. Antimicrobial photodynamic therapy for caseous lymphadenitis abscesses in sheep: report of ten cases. Photodiagnosis Photodyn Ther 13 (2015), 120–202.
41. 41 Tortik, N, Spaeth, A, Plaetzer, K, Photodynamic decontamination of foodstuff from Staphylococcus aureus based on novel formulations of curcumin. Photochem Photobiol Sci 13 (2014), 1402–1409.
42. 42 Meissner, P, Mandi, G, Coulibaly, B, et al. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malar J, 5, 2006, 84.
43. 43 Kairyte, K, Lapinskas, S, Gudelis, V, Luksiene, Z, Effective inactivation of food pathogens Listeria monocytogenes and Salmonella enterica by combined treatment of hypericin-based photosensitization and high power pulsed light. J Appl Microbiol 112 (2013), 1144–1151.
44. 44 WHO. Sixty-third World Health Assembly. Resolutions and decisions annexes. http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf, 2010 (accessed Sept 10, 2016).
45. 45 de Menezes, H, Rodrigues, GB, Teixeira Sde, P, et al. In vitro photodynamic inactivation of plant-pathogenic fungi Colletotrichum acutatum and Colletotrichum gloeosporioides with novel phenothiazinium photosensitizers. Appl Environ Microbiol 80 (2014), 1623–1632.
46. 46 Arrojado, C, Pereira, C, Tome, JP, et al. Applicability of photodynamic antimicrobial chemotherapy as an alternative to inactivate fish pathogenic bacteria in aquaculture systems. Photochem Photobiol Sci 10 (2011), 1691–1700.
47. 47 Almeida, J, Tome, JP, Neves, MG, et al. Photodynamic inactivation of multidrug-resistant bacteria in hospital wastewaters: influence of residual antibiotics. Photochem Photobiol Sci 13 (2014), 626–633.
48. 48 McCoy, CP, O'Neil, EJ, Cowley, JF, et al. Photodynamic antimicrobial polymers for infection control. PLoS One, 9, 2014, e108500.
49. 49 Felgenträger, A, Maisch, T, Späth, A, Schröder, JA, Bäumler, W, Singlet oxygen generation in porphyrin-doped polymeric surface coating enables antimicrobial effects on Staphylococcus aureus. Phys Chem Chem Phys 16 (2014), 20598–20607.
50. 50 Tegos, G, Biodefense: trends and challenges in combating biological warfare agents. Virulence 4 (2013), 740–744.
51. 51 Demidova, T, Hamblin, MR, Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol 71 (2005), 6918–6925.
52. 52 Cassidy, C, Tunney, MM, Magee, ND, et al. Drug and light delivery strategies for photodynamic antimicrobial chemotherapy (PACT) of pulmonary pathogens: a pilot study. Photodiagnosis Photodyn Ther 8 (2011), 1–6.
53. 53 Peiris, JS, Guan, Y, Yuen, KY, Severe acute respiratory syndrome. Nat Med 10:suppl 12 (2004), S88–S97.
54. 54 Abbott, A, Medics braced for fresh superbug. Nature, 436, 2005, 758.
55. 55 Dijkshoorn, L, Neme, A, Seifert, H, An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5 (2007), 939–951.
56. 56 LoBue, P, Sizemore, C, Castro, KG, Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. MMWR Recomm Rep 58 (2009), 1–43.
57. 57 Buffie, C, Pamer, EG, Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13 (2013), 790–801.
58. 58 May, M, Drug development: time for teamwork. Nature 509 (2014), S4–S5.
59. 59 Sung, N, Back, S, Jung, J, et al. Inactivation of multidrug resistant (MDR)-and extensively drug resistant (XDR)-Mycobacterium tuberculosis by photodynamic therapy. Photodiag Photodyn Ther 10 (2013), 694–702.
60. 60 Lopes, R, de Godoy, CH, Deana, AM, et al. Photodynamic therapy as a novel treatment for halitosis in adolescents: study protocol for a randomized controlled trial. Trials, 14, 2014, 443.
61. 61 Figueiredo, SLW, Souza, SV, Botelho, AC, Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis. Dermatol Ther 27 (2014), 43–47.
62. 62 Tardivo, J, Adami, F, Correa, JA, Pinhal, MA, Baptista, MS, A clinical trial testing the efficacy of PDT in preventing amputation in diabetic patients. Photodiagnosis Photodyn Ther 11 (2014), 342–350.
63. 63 Neugebauer, J, Jozsa, M, Kubler, A, Antimicrobial photodynamic therapy for prevention of alveolar ostitis and post-extraction pain. Mund Kiefer Gesichtschir 8 (2004), 350–355.
64. 64 Brown, S, Clinical antimicrobial photodynamic therapy: phase II studies in chronic wounds. J Natl Compr Canc Netw 10:suppl 2 (2012), S80–S83.
65. 65 Morley, S, Griffiths, J, Philips, G, et al. Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobialtherapy. Br J Dermatol 168 (2013), 617–624.
66. 66 Barolet, D, Boucher, A, Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome. Lasers Surg Med 42 (2010), 171–178.
67. 67 Sakamoto, FH, Torezan, L, Anderson, RR, Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy. J Am Acad Dermatol 63 (2010), 195–211.
68. 68 Said, D, Elalfy, MS, Gatzioufas, Z, et al. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology 121 (2014), 1377–1382.
69. 69 Garcez, AS, Nunez, SC, Hamblin, MR, Ribeiro, MS, Antimicrobial effects of photodynamic therapy on patients with necrotic pulps and periapical lesion. J Endod 34 (2008), 138–142.
70. 70 Parker, S, The use of diffuse laser photonic energy and indocyanine green photosensitiser as an adjunct to periodontal therapy. Br Dent J 215 (2013), 167–171.
71. 71 Arciola, CR, Montanaro, L, Costerton, JW, New trends in diagnosis and control strategies for implant infections. Int J Artif Organs 34 (2011), 727–736.
72. 72 Chibebe Junior, J, Fuchs, BB, Sabino, CP, et al. Photodynamic and antibiotic therapy impair the pathogenesis of Enterococcus faecium in a whole animal insect model. PLoS One, 8, 2013, e55926.
73. 73 Tanaka, M, Mroz, P, Dai, T, et al. Linezolid and vancomycin decrease the therapeutic effect of methylene blue-photodynamic therapy in a mouse model of MRSA bacterial arthritis. Photochem Photobiol 89 (2013), 679–688.
74. 74 Wellcome Trust and UK Department of Health. Review on antimicrobial resistance. Tackling drug-resistant infections globally. http://amr-review.org/, 2014 (accessed Oct 16, 2015).
75. 75 US CDC. National strategy for the combating antibiotic-resistant bacteria. http://www.cdc.gov/drugresistance/pdf/carb_national_strategy.pdf, 2014 (accessed Oct 16, 2015).